185 related articles for article (PubMed ID: 29928669)
1. Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer.
Burks J; Nadella S; Mahmud A; Mankongpaisarnrung C; Wang J; Hahm JI; Tucker RD; Shivapurkar N; Stern ST; Smith JP
Cell Mol Gastroenterol Hepatol; 2018; 6(1):17-32. PubMed ID: 29928669
[TBL] [Abstract][Full Text] [Related]
2. Target-Specific Nanoparticle Polyplex Down-Regulates Mutant
Smith JP; Chen W; Shivapurkar N; Gerber M; Tucker RD; Kallakury B; Dasa SSK; Kularatne RN; Stern ST
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614194
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas.
Smith JP; Cao H; Edmondson EF; Dasa SSK; Stern ST
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944412
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.
Monstein HJ; Ohlsson B; Axelson J
Scand J Gastroenterol; 2001 Jul; 36(7):738-43. PubMed ID: 11444473
[TBL] [Abstract][Full Text] [Related]
5. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
[TBL] [Abstract][Full Text] [Related]
6. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
7. Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression.
Matters GL; Harms JF; McGovern CO; Jayakumar C; Crepin K; Smith ZP; Nelson MC; Stock H; Fenn CW; Kaiser J; Kester M; Smith JP
Pancreas; 2009 Jul; 38(5):e151-61. PubMed ID: 19465883
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous cholecystokinin on growth of human pancreatic cancer.
Matters GL; McGovern C; Harms JF; Markovic K; Anson K; Jayakumar C; Martenis M; Awad C; Smith JP
Int J Oncol; 2011 Mar; 38(3):593-601. PubMed ID: 21186400
[TBL] [Abstract][Full Text] [Related]
9.
Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
[TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
11. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.
Goetze JP; Nielsen FC; Burcharth F; Rehfeld JF
Cancer; 2000 Jun; 88(11):2487-94. PubMed ID: 10861424
[TBL] [Abstract][Full Text] [Related]
12. Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
Yang Y; Li J; Liu F; Huang L
Mol Ther; 2012 Mar; 20(3):609-15. PubMed ID: 22186791
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
14. Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma.
Jian Z; Cheng T; Zhang Z; Raulefs S; Shi K; Steiger K; Maeritz N; Kleigrewe K; Hofmann T; Benitz S; Bruns P; Lamp D; Jastroch M; Akkan J; Jäger C; Huang P; Nie S; Shen S; Zou X; Ceyhan GO; Michalski CW; Friess H; Kleeff J; Kong B
Cell Mol Gastroenterol Hepatol; 2018; 6(4):429-449. PubMed ID: 30258965
[TBL] [Abstract][Full Text] [Related]
15. Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.
Jang JY; Kim SW; Ku JL; Park YH; Park JG
World J Gastroenterol; 2005 Feb; 11(6):803-9. PubMed ID: 15682471
[TBL] [Abstract][Full Text] [Related]
16. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer.
Liu Y; Gunda V; Zhu X; Xu X; Wu J; Askhatova D; Farokhzad OC; Parangi S; Shi J
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7750-5. PubMed ID: 27342857
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study.
Monstein HJ; Nylander AG; Salehi A; Chen D; Lundquist I; Håkanson R
Scand J Gastroenterol; 1996 Apr; 31(4):383-90. PubMed ID: 8726308
[TBL] [Abstract][Full Text] [Related]
18. Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines.
Savage K; Waller HA; Stubbs M; Khan K; Watson SA; Clarke PA; Grimes S; Michaeli D; Dhillon AP; Caplin ME
Int J Oncol; 2006 Dec; 29(6):1429-35. PubMed ID: 17088981
[TBL] [Abstract][Full Text] [Related]
19. Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer.
Smith JP; Cao H; Chen W; Mahmood K; Phillips T; Sutton L; Cato A
Front Oncol; 2021; 11():788875. PubMed ID: 34926305
[TBL] [Abstract][Full Text] [Related]
20. iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer.
Lo JH; Hao L; Muzumdar MD; Raghavan S; Kwon EJ; Pulver EM; Hsu F; Aguirre AJ; Wolpin BM; Fuchs CS; Hahn WC; Jacks T; Bhatia SN
Mol Cancer Ther; 2018 Nov; 17(11):2377-2388. PubMed ID: 30097486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
